Glenmede Trust’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,300
| Closed | -$13K | – | 2576 |
|
|
2018
Q1 | $13K | Hold |
3,300
| – | – | ﹤0.01% | 2112 |
|
|
2017
Q4 | $13K | Sell |
3,300
-300
| -8% | -$1.18K | ﹤0.01% | 2112 |
|
|
2017
Q3 | $16K | Sell |
3,600
-9,300
| -72% | -$41.3K | ﹤0.01% | 2049 |
|
|
2017
Q2 | $118K | Hold |
12,900
| – | – | ﹤0.01% | 1342 |
|
|
2017
Q1 | $118K | Sell |
12,900
-10,000
| -44% | -$91.5K | ﹤0.01% | 1342 |
|
|
2016
Q4 | $176K | Hold |
22,900
| – | – | ﹤0.01% | 1243 |
|
|
2016
Q3 | $261K | Sell |
22,900
-5,800
| -20% | -$66.1K | ﹤0.01% | 1124 |
|
|
2016
Q2 | $353K | Hold |
28,700
| – | – | ﹤0.01% | 1019 |
|
|
2016
Q1 | $290K | Hold |
28,700
| – | – | ﹤0.01% | 1064 |
|
|
2015
Q4 | $646K | Hold |
28,700
| – | – | ﹤0.01% | 843 |
|
|
2015
Q3 | $476K | Hold |
28,700
| – | – | ﹤0.01% | 913 |
|
|
2015
Q2 | $645K | Hold |
28,700
| – | – | ﹤0.01% | 854 |
|
|
2015
Q1 | $739K | Hold |
28,700
| – | – | 0.01% | 838 |
|
|
2014
Q4 | $624K | Hold |
28,700
| – | – | ﹤0.01% | 841 |
|
|
2014
Q3 | $543K | Hold |
28,700
| – | – | ﹤0.01% | 850 |
|
|
2014
Q2 | $668K | Hold |
28,700
| – | – | 0.01% | 792 |
|
|
2014
Q1 | $965K | Hold |
28,700
| – | – | 0.01% | 703 |
|
|
2013
Q4 | $847K | Hold |
28,700
| – | – | 0.01% | 720 |
|
|
2013
Q3 | $439K | Buy |
+28,700
| New | +$439K | 0.01% | 858 |
|